Wix.com Gears Up For Q1 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Wix.com Gears Up For Q1 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Wix.com Ltd. (NASDAQ:WIX) is set to release earnings results for its first quarter, before the opening bell on Monday.
Wix.com有限公司（納斯達克股票代碼：WIX）將在週一開盤前公佈其第一季度的收益業績。
Analysts expect the Tel Aviv, Israel-based company to report quarterly earnings at $1.03 per share, up from 91 cents per share in the year-ago period. Wix.com is expected to post revenue of $417.84 million, according to data from Benzinga Pro.
分析師預計，這家總部位於以色列特拉維夫的公司將公佈的季度收益爲每股1.03美元，高於去年同期的每股91美分。根據Benzinga Pro的數據，Wix.com預計將實現4.1784億美元的收入。
Wix.com recently announced the launch of the AI Portfolio Creator, which enhances how users create and showcase an online professional portfolio.
Wix.com最近宣佈推出AI Portfolio Creator，它增強了用戶創建和展示在線專業作品集的方式。
Wix.com shares slipped 1.6% to close at $135.21 on Thursday.
週四，Wix.com股價下跌1.6％，收於135.21美元。
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Benzinga的讀者可以在分析師股票評級頁面上訪問最新的分析師評級。讀者可以按股票行情、公司名稱、分析公司、評級變化或其他變量進行排序。
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
讓我們來看看Benzinga最準確的分析師在最近一段時間對該公司的評級。
- Benchmark analyst Mark Zgutowicz reiterated a Buy rating with a price target of $175 on May 15. This analyst has an accuracy rate of 66%.
- JMP Securities analyst Andrew Boone reiterated a Market Outperform rating with a price target of $150 on April 30. This analyst has an accuracy rate of 73%.
- Raymond James analyst Josh Beck reinstated an Outperform rating with a price target of $160 on March 27. This analyst has an accuracy rate of 74%.
- RBC Capital analyst Brad Erickson maintained an Outperform rating and boosted the price target from $135 to $160 on Feb. 22. This analyst has an accuracy rate of 69%.
- Piper Sandler analyst Clarke Jeffries maintained an Overweight rating and increased the price target from $146 to $165 on Feb. 22. This analyst has an accuracy rate of 61%.
- 基準分析師馬克·茲古托維奇在5月15日重申了買入評級，目標股價爲175美元。這位分析師的準確率爲66％。
- JMP證券分析師安德魯·布恩在4月30日重申了市場跑贏大盤的評級，目標股價爲150美元。這位分析師的準確率爲73％。
- 雷蒙德·詹姆斯分析師喬什·貝克於3月27日恢復了跑贏大盤的評級，目標股價爲160美元。這位分析師的準確率爲74％。
- 加拿大皇家銀行資本分析師布拉德·埃裏克森維持跑贏大盤的評級，並於2月22日將目標股價從135美元上調至160美元。該分析師的準確率爲69％。
- 派珀·桑德勒分析師克拉克·傑弗里斯維持增持評級，並於2月22日將目標股價從146美元上調至165美元。該分析師的準確率爲61％。
Read This Next: Over $1M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
接下來閱讀這篇文章：押注超過100萬美元的醫療保健股票？看看內部人士正在買入的這3只股票
譯文內容由第三人軟體翻譯。